Headlines describing a hepatitis B cure may overstate early results because the treatment achieved a functional cure in only a minority of trial participants. Researchers still lack long-term evidence proving patients remain permanently virus-free, while side effects, accessibility and high treatment costs remain concerns. Chronic hepatitis B remains challenging, and broader studies are necessary before celebrating a cure.